Therapeutic Uses
Anti-Diabetic
Storage Condition
Store at refrigerator (2-8°C) for long term storage
Synonyms
MonoAcetyl Dapagliflozin
Application Notes
Useful research chemical for a range of applications
Hazard Compound
No -Refer MSDS for accurate information
MonoAcetyl Dapagliflozin is a drug product that is used as an analytical standard for HPLC, as well as in research and development of drugs.
Refund Policy
We are committed to offering products of the highest quality in order to meet the needs of our customers, and have elaborate systems in
place to ensure that material specifications, their certification and all handling and storage conditions are communicated at the time of
material handover.
We have invested in the highest quality packaging materials and use international logistics partners to service our customers. While all
possible precautions have been taken to deliver the required product(s), there may be some rare situations when our product does not
meet your requirements. Should that arise, please contact us with your concerns and we will endeavour to address them on a priority
basis. If there is no other option, we will either replace your product(s) or issue a refund or account credit, whichever you prefer.
If there is an issue with one or more of our products, our policy is that it must be reported to us within 45 days of your receiving shipment.
While we will always address product issues after the 45 day return window has passed, we cannot issue a refund or account credit. As
always, we appreciate your support.
MonoAcetyl Dapagliflozin usage and description
MonoAcetyl Dapagliflozin is a medication used to treat Type 2 diabetes. It is an inhibitor of the sodium-glucose co-transporter 2 (SGLT2), which is responsible for reabsorbing glucose in the kidney. By inhibiting this process, MonoAcetyl Dapagliflozin allows glucose to be excreted in the urine, resulting in lower blood glucose levels.
Chemically, MonoAcetyl Dapagliflozin is a derivative of Dapagliflozin, an SGLT2 inhibitor. It is a white to off-white powder with a molecular formula of C22H24ClNaO8S and a molecular weight of 506.93 g/mol.
MonoAcetyl Dapagliflozin is administered orally in tablet form, with a recommended dose of 10 mg per day. It is typically taken in the morning, with or without food. It is important to note that MonoAcetyl Dapagliflozin should not be used to treat Type 1 diabetes or diabetic ketoacidosis.
Like all medications, MonoAcetyl Dapagliflozin may cause side effects, including urinary tract infections, genital infections, and dehydration. It may also increase the risk of diabetic ketoacidosis in certain patients. It is important to discuss any potential side effects with a healthcare provider before starting treatment with MonoAcetyl Dapagliflozin.
